Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Purpose: Allogeneic hematopoietic stem-cell transplantation (HSCT) is potentially curative for acute leukemia (AL), but carries considerable risk. Machine learning algorithms, which are part of the data mining (DM) approach, may serve for transplantation-related mortality risk prediction. Patients and Methods: This work is a retrospective DM study on a cohort of 28,236 adult HSCT recipients from the AL registry of the European Group for Blood and Marrow Transplantation. The primary objective was prediction of overall mortality (OM) at 100 days after HSCT. Secondary objectives were estimation of nonrelapse mortality, leukemia-free survival, and overall survival at 2 years. Donor, recipient, and procedural characteristics were analyzed. The alternating decision tree machine learning algorithm was applied for model development on 70% of the data set and validated on the remaining data. Results: OM prevalence at day 100 was 13.9% (n = 3,936). Of the 20 variables considered, 10 were selected by the model for OM prediction, and several interactions were discovered. By using a logistic transformation function, the crude score was transformed into individual probabilities for 100-day OM (range, 3% to 68%). The model's discrimination for the primary objective performed better than the European Group for Blood and Marrow Transplantation score (area under the receiver operating characteristics curve, 0.701 v 0.646; P < .001). Calibration was excellent. Scores assigned were also predictive of secondary objectives. Conclusion: The alternating decision tree model provides a robust tool for risk evaluation of patients with AL before HSCT, and is available online ( http://bioinfo.lnx.biu.ac.il/∼bondi/web1.html ). It is presented as a continuous probabilistic score for the prediction of day 100 OM, extending prediction to 2 years. The DM method has proved useful for clinical prediction in HSCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author)
Breiman, L. (2001) · Statistical Science · doi:10.1214/ss/1009213726 · Cited by 4,340 · cited 2×
“A DM method has been applied in fields such as communication andfinance, and one can think of potential uses in HSCT, because it allows prediction of the outcome of interest without strong assumptions regarding the distribution of the variables and the regression model used.(11,12) It is reassuring that the Cox and AD…”
MethodSorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Self-citationPrognosis and prognostic research: Developing a prognostic model
Royston, P., Moons, K. G. M., Altman, D. G., & Vergouwe, Y. (2009) · BMJ · doi:10.1136/bmj.b604 · Cited by 1,172
The Comparison and Evaluation of Forecasters
DeGroot, M. H., & Fienberg, S. E. (1983) · The Statistician · doi:10.2307/2987588 · Cited by 604 · cited 1×
“The quality of the score after calibration was evaluated through a reliability diagram, which verified that in each score interval, defined according to the deciles, the mean score was consistent with the observed proportions of events.(22,23) The prediction model’s discriminationwas assessed using the area under the…”
MethodThe Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?
Lauer, M. S., & D'Agostino, R. B. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1310102 · Cited by 595 · cited 1×
“However, the registry analyzed reflects real world data, conveying contemporary practice.(10) Second, validation was done on an internal data set, and external validation is warranted.”
Method
Cited by
Snowden, J. A., Sánchez-Ortega, I., Corbacioglu, S., Basak, G. W., Chabannon, C., de la Camara, R., Dolstra, H., Duarte, R. F., Glass, B., Greco, R., et al. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01691-w · Cited by 379
Self-citationfor the European Society for Blood and Marrow Transplantation (EBMT), Duarte, R. F., Labopin, M., Bader, P., Basak, G. W., Bonini, C., Chabannon, C., Corbacioglu, S., Dreger, P., Dufour, C., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0516-2 · Cited by 337
Self-citation
Metadata
- Authors
- Shouval, R., Labopin, M., Bondi, O., Mishan-Shamay, H., Shimoni, A., Ciceri, F., Esteve, J., Giebel, S., Gorin, N. C., Schmid, C., Polge, E., Aljurf, M., Kroger, N., Craddock, C., Bacigalupo, A., Cornelissen, J. J., Baron, F., Unger, R., Nagler, A., & Mohty, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-10-01
- Volume
- 33
- Issue
- 28
- Pages
- 3144-3151
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2133048986
- Cited by
- 166
- References
- 5
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study. https://app.cochat.ai/papers/10.1200/jco.2014.59.1339
- The paper
- Shouval, R., Labopin, M., Bondi, O., Mishan-Shamay, H., Shimoni, A., Ciceri, F., Esteve, J., Giebel, S., Gorin, N. C., Schmid, C., Polge, E., Aljurf, M., Kroger, N., Craddock, C., Bacigalupo, A., Cornelissen, J. J., Baron, F., Unger, R., Nagler, A., & Mohty, M. (2015). Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2014.59.1339
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.